Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Genome-wide association of familial late-onset alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

Wijsman, EM and Pankratz, ND and Choi, Y and Rothstein, JH and Faber, KM and Cheng, R and Lee, JH and Bird, TD and Bennett, DA and Diaz-Arrastia, R and Goate, AM and Farlow, M and Ghetti, B and Sweet, RA and Foroud, TM and Mayeux, R (2011) Genome-wide association of familial late-onset alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genetics, 7 (2). ISSN 1553-7390

Published Version
Available under License : See the attached license file.

Download (2MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p = 3.2×10-81), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE ε4 homozygotes (e.g., rs201119, p = 1.5×10-8). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p = 0.009 with, and p = 0.03 without, APOE adjustment) and CLU (rs11136000, p = 0.023 with, and p = 0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p = 0.69 with, and p = 0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies. © 2011 Wijsman et al.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Wijsman, EM
Pankratz, ND
Choi, Y
Rothstein, JH
Faber, KM
Cheng, R
Lee, JH
Bird, TD
Bennett, DA
Diaz-Arrastia, R
Goate, AM
Farlow, M
Ghetti, B
Sweet, RAsweet@pitt.eduSWEET
Foroud, TM
Mayeux, R
Date: 1 February 2011
Date Type: Publication
Journal or Publication Title: PLoS Genetics
Volume: 7
Number: 2
DOI or Unique Handle: 10.1371/journal.pgen.1001308
Refereed: Yes
ISSN: 1553-7390
MeSH Headings: Adaptor Proteins, Signal Transducing--genetics; Aged; Alzheimer Disease--genetics; Apolipoproteins E--genetics; Apolipoproteins E--metabolism; Case-Control Studies; Clusterin--genetics; European Continental Ancestry Group--genetics; Family; Gene Frequency--genetics; Genetic Predisposition to Disease; Genome, Human--genetics; Genome-Wide Association Study; Heterozygote; Humans; Middle Aged; Nerve Tissue Proteins--genetics; Nerve Tissue Proteins--metabolism; Nuclear Proteins--genetics; Polymorphism, Single Nucleotide--genetics; Population Dynamics; Principal Component Analysis; Protein Binding; RNA-Binding Proteins--genetics; RNA-Binding Proteins--metabolism; Reproducibility of Results; Tumor Suppressor Proteins--genetics
Other ID: NLM PMC3040659
PubMed Central ID: PMC3040659
PubMed ID: 21379329
Date Deposited: 07 Aug 2012 15:44
Last Modified: 22 Jun 2021 14:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item